Compare Tesla, Inc. (TSLA) vs Viatris Inc (VTRS) Price & Performance

Tesla, Inc.Trade

Viatris IncTrade

Price performance (Past 24H)

Key statistics

Tesla, Inc. vs Viatris Inc — how do they compare? Tesla, Inc. trades at $379.35 (market cap $1.39T), while Viatris Inc trades at $17.58 (market cap $19.79B). The key difference: Tesla, Inc. is far larger — about 70.2× Viatris Inc's market cap, and Viatris Inc pays a 2.83% dividend while Tesla, Inc. pays none. Which is the better fit depends on your goals.

	TSLA	VTRS
Market Cap	$1.39T	$19.79B
Sector	Consumer Cyclical	Health
52-Week High	$489.88	$17.39
52-Week Low	$302.63	$8.74
Enterprise Value	$1.36T	$32.00B
Dividend Yield	—	2.83%

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Tesla, Inc.

Tesla (TSLA) trades at $378.88, down 0.51% on the day, as the stock faces technical bearish signals despite recent earnings beats. The company shows mixed fundamentals with revenue declining to $94.83B in 2025 and net income margin compressing to 3.95%, while valuation multiples remain elevated with a P/E of 339.06. Recent news highlights Tesla's strategic pivot toward robotics, AI, and energy growth amid a slowing auto business, with regulatory approval for driver-assistance software in Europe providing a potential catalyst.

Tesla's investment case balances high-growth potential in autonomy and energy against near-term execution risks and rich valuations. The consensus price target of $409.26 suggests modest upside, but investors face headwinds from competitive pressures and margin compression. The stock's trajectory will likely hinge on successful commercialization of new technologies and improved automotive profitability.

Viatris Inc

No Aura AI signal available yet.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

TSLA

Roundhill Magnificent Seven ETF offers equal exposure to top 7 mega-cap tech stocks but with higher risk and cost.24/7 Wall Street · 5 hours agoNeutral Northrop Grumman CEO hints space robots could be weaponized, leaving decision to US government.Forbes · 5 hours agoBullish Options traders expect Tesla's biggest post-earnings move in a year, with a 5.76% price swing implied.CNBC · 6 hours agoNeutral View details →

VTRS

View details →

About Tesla, Inc.

Tesla Inc. designs, manufactures, and sells high-performance electric vehicles and electric vehicle powertrain components. The Company owns its sales and service network and sells electric power train components to other automobile manufacturers. Tesla serves customers worldwide.

About Viatris Inc

Formed by the combination of Mylan and Pfizer's Upjohn business in 2020, Viatris is one of the world's largest generic drug manufacturers, with a substantial off-patent branded drug portfolio. Its portfolio consists of more than 1,400 molecules with penetration across most of the developed world and in select emerging markets. The company's branded drug portfolio consists of off-patent blockbuster drugs that continue to generate strong sales, including Lipitor, Norvasc, Lyrica, Viagra, and EpiPen. While global competition has facilitated the commodification of small-molecule generic drugs, the company has demonstrated an edge over peers in its ability to manufacture complex generics (for example, generic Advair and Copaxone).